Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Annals of Diagnostic Pathology
|
September 25, 2020
Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients
Linfang Wen, Shenghao Wang, Weiran Xu, et al.
Frontiers in Oncology
|
March 21, 2022
Case Report: Complete Remission With Anti-PD-1 and Anti-VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma
Weiran Xu, Kai Wang, Wenguang Gu, et al.
Thoracic Cancer
|
August 27, 2024
Immune-inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD-L1 ≥50% metastatic non-small cell lung cancer receiving first-line immunotherapy
Xixi Zheng, Lili Zhou, Hui Shi, et al.
Cell Death Discovery
|
September 4, 2023
In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma
Li Li, Tao Xing, Yiran Chen, et al.
Thoracic Cancer
|
August 22, 2023
Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations
Xiaosheng Ding, Weiwei Shi, Bingxuan Han, et al.
Oncology Letters
|
March 29, 2020
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma
Li Li, Xiaosong Rao, Zhaohong Wen, et al.
Biomarkers in Medicine
|
March 26, 2021
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma
Jing Zhao, Weiran Xu, Yu Zhang, et al.
Oncology Letters
|
July 18, 2018
Cytoplasmic expression of estrogen receptor β may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma
Xiaosheng Ding, Li Li, CHuanhao Tang, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Acta Neuropathologica Communications
|
June 25, 2026
Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer
Xiudong Guan, Yubing Li, Zongkun Shi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Annals of Diagnostic Pathology
|
September 25, 2020
Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients
Linfang Wen, Shenghao Wang, Weiran Xu, et al.
Frontiers in Oncology
|
March 21, 2022
Case Report: Complete Remission With Anti-PD-1 and Anti-VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma
Weiran Xu, Kai Wang, Wenguang Gu, et al.
Thoracic Cancer
|
August 27, 2024
Immune-inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD-L1 ≥50% metastatic non-small cell lung cancer receiving first-line immunotherapy
Xixi Zheng, Lili Zhou, Hui Shi, et al.
Cell Death Discovery
|
September 4, 2023
In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma
Li Li, Tao Xing, Yiran Chen, et al.
Thoracic Cancer
|
August 22, 2023
Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations
Xiaosheng Ding, Weiwei Shi, Bingxuan Han, et al.
Oncology Letters
|
March 29, 2020
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma
Li Li, Xiaosong Rao, Zhaohong Wen, et al.
Biomarkers in Medicine
|
March 26, 2021
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma
Jing Zhao, Weiran Xu, Yu Zhang, et al.
Oncology Letters
|
July 18, 2018
Cytoplasmic expression of estrogen receptor β may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma
Xiaosheng Ding, Li Li, CHuanhao Tang, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Acta Neuropathologica Communications
|
June 25, 2026
Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer
Xiudong Guan, Yubing Li, Zongkun Shi, et al.
Page
of 4